why do companies run trials…
To see if treatments are comm a possibility of taking to market to make money for shareholders?
Or just run them and use your money for sh$ts and giggles?
it would appear your thoughts align with number 2
When something ends in “that is the question” generally you would think (obviously some bright cookies don’t) it is a question
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?, page-261
-
- There are more pages in this discussion • 131 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.61 |
Change
-0.050(3.01%) |
Mkt cap ! $278.6M | |||
| Open | High | Low | Value | Volume |
| $1.68 | $1.68 | $1.61 | $50.78K | 31.31K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 16249 | $1.61 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.62 | 930 | 1 |
View Market Depth
| Last trade - 11.05am 06/09/2024 (20 minute delay) ? |
| RAC (ASX) Chart |